Kazakhstan and India are stepping up efforts to deepen cooperation in the pharmaceutical sector, as highlighted during the “Kazakhstan–India Pharma Business Meeting” held in Almaty, DKNews.kz reports.
The forum brought together government officials, investors and leading pharmaceutical companies, signaling growing interest in joint projects and long-term partnerships.
Business interest on both sides
The event gathered representatives of major Indian pharmaceutical companies, including:
- Acies Pharmaceutical Pvt. Ltd.
- Abaris Healthcare Pvt. Ltd.
- Akriti Pharmaceuticals Pvt Ltd.
- AMTEC Health Care Pvt Ltd.
Their participation reflects increasing engagement between the business communities of Kazakhstan and India, particularly in healthcare and pharmaceutical production.
Education as a bridge to future cooperation
Deputy Foreign Minister Alibek Kuantyrov pointed to strong educational ties as a foundation for deeper collaboration.
“More than 12 thousand Indian students currently study in Kazakhstan, with the majority enrolled in medical universities. This reflects the high level of trust in Kazakhstan’s education system and creates a strong foundation for future ties in healthcare and medical research. A clear example of this is the recent investment project by India’s MSN Group to construct a full-cycle pharmaceutical plant in the Almaty region”, Alibek Kuantyrov noted.
Almaty as a growing pharma hub
Akim of Almaty Darkhan Satybaldy highlighted the rapid development of the city’s pharmaceutical sector.
He noted progress in several areas:
- creation of modern industrial clusters
- opening of research centers
- launch of new pharmaceutical production facilities
These developments position Almaty as a key hub for pharmaceutical innovation and manufacturing in the region.
Investment opportunities and localization
During the forum, “Kazakh Invest” presented Kazakhstan’s investment potential and opportunities in the pharmaceutical industry.
Indian businesses were encouraged to expand their presence in the country through:
- localization of medicine production
- development of medical equipment manufacturing
- participation in joint research and innovation projects
Ambassador of India to Kazakhstan Y.K. Sailas Thangal emphasized the importance of the forum in strengthening long-term economic ties.
Why this matters
The growing partnership between Kazakhstan and India in pharmaceuticals reflects broader economic and strategic trends.
Key implications include:
- diversification of Kazakhstan’s economy beyond raw materials
- strengthening healthcare infrastructure and drug availability
- attraction of foreign investment and technology transfer
- development of high-value manufacturing sectors
For India, cooperation with Kazakhstan opens new access points to Central Asian markets and strengthens its global pharmaceutical footprint.
The Almaty forum demonstrates that both countries are moving from dialogue to practical cooperation in a sector critical for public health and economic resilience.
